In a statement posted on its website on Tuesday (02/24), Sciwind called the deal "an important first step to advance Pfizer's global strategy in the metabolic field in China." Ecnoglutide itself already got the green light from Chinese regulators back in January 2026 for treating type 2 diabetes
If you have a history of prevalent stomach issues, they can help you make an informed decision
Kawai M, de Paula FJA, Rosen CJ (2012) New insights into osteoporosis: the bone-fat connection
North America held a major market share of 57% in 2025
While PlexusDx providers recommend you maintain contact with your primary care doctor regarding blood pressure medication adjustments, PlexusDx tracks your clinical response and helps coordinate care
This leads to: Longer-lasting fullness Smaller portion sizes naturally Less snacking between meals Reduced late-night hunger This is a major part of GLP-1 weight loss , because the longer you feel satisfied, the easier it is to stay consistent with healthier eating habits